Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 96
Filter
Add more filters











Publication year range
1.
Chem Commun (Camb) ; 52(28): 5011-4, 2016 Apr 11.
Article in English | MEDLINE | ID: mdl-26981920

ABSTRACT

A photoanode prepared from flux-synthesized Al-doped SrTiO3 by the particle transfer method with a Ta contact layer exhibited a high IPCE of 69% at 320 nm. The photocatalytic activity of SrTiO3 particles was very sensitive to the synthesis method used to make the SrTiO3 particles, while its photoelectrochemical performance was not.

2.
Br J Cancer ; 109(7): 1760-5, 2013 Oct 01.
Article in English | MEDLINE | ID: mdl-24002604

ABSTRACT

BACKGROUND: Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. METHODS: The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. RESULTS: A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction. CONCLUSION: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies.


Subject(s)
Adenocarcinoma/mortality , Adenocarcinoma/surgery , Endometrial Neoplasms/surgery , Hysterectomy , Uterine Cervical Neoplasms/surgery , Body Mass Index , Cervix Uteri/surgery , Disease-Free Survival , Endometrial Neoplasms/mortality , Female , Humans , Hysterectomy/adverse effects , Middle Aged , Retrospective Studies , Survival Rate , Treatment Outcome , Uterine Cervical Neoplasms/mortality
3.
J Endocrinol Invest ; 36(7): 515-20, 2013.
Article in English | MEDLINE | ID: mdl-23385491

ABSTRACT

BACKGROUND: Accumulating evidence supports the idea of activin A as a modulator of inflammation. In human pregnancy, elevated activin A concentrations in amniotic fluid are reported in women with intra-amniotic infection and inflammation- induced pre-term birth. AIM: To test the hypothesis that activin A was involved in the pathophysiology of amnionitis, we evaluated the effects of tumor necrosis factor-α and lipopolysaccharide on activin A production in human amniotic epithelial cells, and the effects of activin A on the expression of collagen mRNA in amniotic mesenchymal cells. MATERIALS AND METHODS: Amniotic membranes were obtained from patients without systemic disease, signs of premature delivery or fetal complications, during elective cesarean sections at term. Amniotic epithelial cells and mesenchymal cells were separately obtained by enzymatic digestion and cultured. Activin A was measured by enzyme-linked immunosorbent assay and collagen mRNA levels were assessed by quantitative PCR. RESULTS: Amniotic epithelial cells produced activin A in a cell density- and time-dependent manner. Tumor necrosis factor- α enhanced activin A production in a time-dependent (48-120 h) and dose-dependent (10-300 ng/ml) manner in amniotic epithelial cells. Lipopolysaccharide also stimulated activin A production, but the effect was less prominent. In amniotic mesenchymal cells, the effect of activin A on the expression of type I and type III collagen mRNA was suppressive. CONCLUSIONS: Tumor necrosis factor-α and lipopolysaccharide stimulated activin A production in amniotic epithelial cells, and activin A modulated expression of collagen mRNA in amniotic mesenchymal cells. These results support the idea that activin A is involved in the pathophysiology of amnionitis.


Subject(s)
Activins/metabolism , Amnion/metabolism , Collagen Type III/biosynthesis , Collagen Type I/biosynthesis , Epithelial Cells/metabolism , Tumor Necrosis Factor-alpha/physiology , Activins/biosynthesis , Amnion/cytology , Cells, Cultured , Chorioamnionitis/physiopathology , Epithelial Cells/drug effects , Female , Humans , Mesoderm/metabolism , Pregnancy , RNA, Messenger/metabolism , Tumor Necrosis Factor-alpha/pharmacology
4.
J Radiol Prot ; 33(1): 151-62, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23295242

ABSTRACT

Previous research examining radon exposure from granite countertops relied on using a limited number of exposure scenarios. We expanded upon this analysis and determined the probability that installing a granite countertop in a residential home would lead to a meaningful radon exposure by performing a Monte Carlo simulation to obtain a distribution of potential indoor radon concentrations attributable to granite. The Monte Carlo analysis included estimates of the probability that a particular type of granite would be purchased, the radon flux associated with that type, the size of the countertop purchased, the volume of the home where it would be installed and the air exchange rate of that home. One million countertop purchases were simulated and 99.99% of the resulting radon concentrations were lower than the average outdoor radon concentrations in the US (14.8 Bq m(-3); 0.4  pCi l(-1)). The median predicted indoor concentration from granite countertops was 0.06 Bq m(-3) (1.59 × 10(-3) pCi l(-1)), which is over 2000 times lower than the US Environmental Protection Agency's action level for indoor radon (148 Bq m(-3); 4 pCi l(-1)). The results show that there is a low probability of a granite countertop causing elevated levels of radon in a home.


Subject(s)
Air Pollution, Indoor/analysis , Air Pollution, Indoor/statistics & numerical data , Air Pollution, Radioactive/analysis , Air Pollution, Radioactive/statistics & numerical data , Construction Materials/analysis , Models, Statistical , Radon/analysis , Computer Simulation , Construction Materials/statistics & numerical data , Monte Carlo Method , Radiation Dosage , Radiation Monitoring/methods
5.
Int J Gynecol Cancer ; 17(2): 426-32, 2007.
Article in English | MEDLINE | ID: mdl-17309563

ABSTRACT

Clear cell adenocarcinoma of the ovary has a poor prognosis due to chemoresistance and early metastasis to the lymph nodes. It also can result in endometriosis and is the second most frequent type of ovarian cancer in Japan. Serous adenocarcinoma of the ovary is another common epithelial cancer tissue subtype in Japan, and it is highly sensitive to chemotherapy. In the current study, we examined the differential expression of genes in these types of ovarian cancer and tried to analyze their functions, especially as they relate to chemoresistance. We used differential display to compare clear cell carcinoma and serous adenocarcinoma of the ovary. We identified sperm protein 17 (SP17) as a candidate gene related to the chemoresistance of clear cell carcinoma. Its differential expression was confirmed by real-time polymerase chain reaction. Because the function of the SP17 gene in ovarian cancer is not known, we examined the effect of small interfering RNA targeting the SP17 gene on the chemoresistance and proliferation of ES-2 ovarian cancer cells to paclitaxel, currently the most effective treatment for ovarian cancer. We found that this treatment decreased the chemoresistance of these cells to paclitaxel. Our results strongly suggest that SP17 plays a role in the resistance of clear cell carcinoma to chemotherapy without influencing their ability to proliferate.


Subject(s)
Adenocarcinoma, Clear Cell/genetics , Adenocarcinoma, Clear Cell/pathology , Antigens, Surface/genetics , Carrier Proteins/genetics , Drug Resistance, Neoplasm/genetics , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Adenocarcinoma, Clear Cell/metabolism , Antigens, Surface/metabolism , Calmodulin-Binding Proteins , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/metabolism , Cells, Cultured , Cystadenocarcinoma, Serous/genetics , Cystadenocarcinoma, Serous/metabolism , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Humans , Membrane Proteins , Ovarian Neoplasms/metabolism , RNA, Small Interfering/pharmacology , Reverse Transcriptase Polymerase Chain Reaction
6.
Eur J Cancer ; 42(7): 934-47, 2006 May.
Article in English | MEDLINE | ID: mdl-16540312

ABSTRACT

Paclitaxel, a potent anti-neoplastic agent, has been found to be effective against several tumours, including cervical cancer. However, the exact mechanism underlying the cytotoxic effects of pacitaxel, especially in the survival-signalling pathway, is poorly understood. The aim of this study was to investigate the molecular pathway of the cytotoxic effect of paclitaxel in human cervical cancer cell lines. Four human cervical cancer cell lines were treated for 24 h with various concentration of paclitaxel, and the sensitivity was analysed by an MTT assay. The cell cycle progression and sub-G1 population were analysed by flow cytometry. Apoptosis was further measured by DNA fragmentation and microscope examination. The protein expression was determined by Western blot analysis. Our results showed that HeLa cells demonstrated the highest sensitivity to paclitaxel, whereas CaSki cells showed the lowest. In cervical cancer cells, paclitaxel induced apoptosis through an intrinsic pathway with prior G2/M arrest. In addition, we showed that paclitaxel downregulated the phosphorylation of Akt in both HeLa and CaSki cells. Interestingly, in CaSki cells, which were more suggestive of a resistant phenotype, paclitaxel induced the activation of mTOR as a downstream target of Akt. Pre-treatment with rapamycin inhibited activation of mTOR signalling and significantly enhanced the sensitivity of CaSki cells to paclitaxel by increasing apoptotic cell death. This effect was mediated, at least partly, through caspase activation. Overall, paclitaxel exerts its anti-tumour effects on cervical cancer cells by inducing apoptosis through intrinsic pathway, and rapamycin targeted to mTOR can sensitise paclitaxel-resistant cervical cancer cells.


Subject(s)
Antineoplastic Agents/pharmacology , Paclitaxel/pharmacology , Protein Kinases/drug effects , Sirolimus/pharmacology , Uterine Cervical Neoplasms/drug therapy , Apoptosis/drug effects , Blotting, Western , Cell Communication , Cell Cycle/drug effects , Cell Line, Tumor , DNA, Neoplasm/analysis , Dose-Response Relationship, Drug , Down-Regulation , Drug Screening Assays, Antitumor , Female , HeLa Cells , Humans , Phosphatidylinositol 3-Kinases/metabolism , Sirolimus/administration & dosage , TOR Serine-Threonine Kinases , Uterine Cervical Neoplasms/pathology
7.
Placenta ; 26(4): 298-307, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15823616

ABSTRACT

Human gonads and non-gonadal organs/tissues express luteinizing hormone/chorionic gonadotropin (LH/CG) receptors. This study aimed to identify the LH/CG receptors and to clarify their function in human placental chorionic villous macrophages. Macrophages as well as syncytiotrophoblasts of human chorionic villous tissues were immunohistochemically positive for LH/CG receptor throughout gestation. By reverse transcription-nested polymerase chain reaction methods, villous macrophages were shown to express a variant type of LH/CG receptor, the sequencing of which revealed a deletion of exon 9. For experiments in vitro, a monocyte-macrophage cell line, THP-1, was transfected with vector alone, wild-type LH/CG receptor, and exon 9-deleted LH/CG receptor after phorbol 12-myristate 13-acetate (PMA) treatment. Non-PMA-treated THP-1 cells transfected with vector alone were also examined. THP-1 cells expressed exon 9-deleted LH/CG receptor after treatment with PMA. After the cells of the four groups were cultured in medium containing intact human CG (hCG), the concentrations of hCG and its beta-core fragment (beta-CF) were measured in the supernatant of the culture medium and in the cell cytosol. Time-dependent hCG uptake was observed in both non-PMA-treated and PMA-treated THP-1 cells, suggesting that the variant receptor is not directly involved in the ingestion of hCG. The degradation of hCG and excretion of beta-CF were progressed in PMA-treated cells but not in the un-treated cells. In the cell cytosol, the ratio of beta-CF and hCG concentrations (beta-CF/hCG) was significantly higher in the PMA-treated cells than in non-PMA-treated cells; however, it did not differ between the PMA-treated cells transfected with exon 9-deleted receptor and those transfected with vector alone. Macrophages may express the variant receptor in order to recognize the intracytoplasmic hCG and transport it to the lysosome. Among the two PMA-treated cells, the ratio was lower in those transfected with wild-type receptor. The expression of the variant receptor may modulate the degradation of hCG but be reduced by expression of the wild-type receptor in its lacking macrophages. Our data suggest a potentially important role for exon 9-deleted LH/CG receptors expressed in human placental villous macrophages in the local metabolism of hCG.


Subject(s)
Chorionic Gonadotropin/metabolism , Chorionic Villi/metabolism , Luteinizing Hormone/metabolism , Macrophages/metabolism , Receptors, LH/metabolism , Base Sequence , Cell Line , Chorionic Villi/ultrastructure , Female , Gene Expression Regulation , Genetic Variation , Humans , Immunohistochemistry , Luteinizing Hormone/analysis , Luteinizing Hormone/genetics , Molecular Sequence Data , Pregnancy , RNA, Messenger/metabolism , Receptors, LH/analysis , Receptors, LH/genetics
8.
Eat Weight Disord ; 10(4): 264-6, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16755171

ABSTRACT

A recently recognized peptide, ghrelin, increases appetite and energy retention in human. Previous reports have shown higher plasma level in eating disorder (ED) patients and correlations with body mass index (BMI). This study examined these findings by measuring active (N-RIA) and total (C-RIA) levels of plasma ghrelin. Multipurpose assessments of symptoms were conducted for 11 ED patients and 5 control females. Results revealed significant differences of C-RIA between the groups. The BMI did not correlate with ghrelin, but demonstrated reversal correlation with the ratio of N-RIA and C-RIA (NC ratio) according to the ED or control group. The NC ratio also tended to be associated with a self-rating score. The NC ratio might be related to specific characteristics of ghrelin secretion or clearance in ED patients. Further basic and clinical investigations are necessary.


Subject(s)
Feeding and Eating Disorders/blood , Peptide Hormones/blood , Peptide Hormones/chemistry , Adolescent , Adult , Body Mass Index , Case-Control Studies , Female , Ghrelin , Humans , Self Concept
9.
Toxicol Lett ; 125(1-3): 61-5, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11701223

ABSTRACT

Although nicotine has been implicated as a potential factor in the pathogenesis of cancer in humans, its mechanism of action in the development of cancer remains largely unknown. Growing evidence indicates that the induction of apoptosis is an important mechanism in the prevention of cancer development. In the study presented here, we examined the effects of nicotine on the process of apoptosis. Preincubation of human cells with nicotine completely inhibited ultraviolet light (UV)-induced apoptosis. The inhibition of apoptosis by nicotine was correlated with the prevention of cytochrome c release and caspase activation, which are essential components of the UV-induced apoptotic pathway. Thus, our results suggest that the inhibition of apoptosis by nicotine contributes to the increased incidence of cancer in smokers.


Subject(s)
Apoptosis/drug effects , Nicotine/toxicity , Apoptosis/radiation effects , Caspase 3 , Caspases/physiology , Cytochrome c Group/metabolism , Enzyme Activation , Humans , U937 Cells , Ultraviolet Rays
10.
Gene ; 273(2): 251-7, 2001 Aug 08.
Article in English | MEDLINE | ID: mdl-11595171

ABSTRACT

A comparative study of natriuretic peptide receptor (NPR) was performed by cloning the NPR-A receptor subtype from the bullfrog (Rana catesbeiana) brain and analyzing its functional expression. Like other mammalian NPR-A receptors, the bullfrog NPR-A receptor consists of an extracellular ligand binding domain, a hydrophobic transmembrane domain, a kinase-like domain and a guanylate cyclase domain. Sequence comparison among the bullfrog and mammalian receptors revealed a relatively low ( approximately 45%) similarity in the extracellular domain compared to a very high similarity ( approximately 92%) in the cytoplasmic regulatory and catalytic domains. Expression of NPR-A mRNA was detected in various bullfrog tissues including the brain, heart, lung, kidney and liver; highest levels were observed in lung. Functional expression of the receptor in COS-7 cells revealed that frog atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) elicited cyclic guanosine 3'5'-monophosphate production by stimulating the receptor in a dose-dependent manner from 10(-10) M concentrations. Rat ANP was also effective in stimulating the frog receptor whereas rat BNP and porcine BNP were less responsive to the receptor. On the other hand, frog C-type natriuretic peptide (CNP) as well as porcine CNP stimulated the receptor only at high concentrations (10(-7) M). This clearly indicates that the bullfrog receptor is a counterpart of mammalian NPR-A, and is specific for ANP or BNP but not for CNP.


Subject(s)
Guanylate Cyclase/genetics , Rana catesbeiana/genetics , Receptors, Atrial Natriuretic Factor/genetics , Amino Acid Sequence , Animals , Atrial Natriuretic Factor/pharmacology , Base Sequence , Blotting, Northern , COS Cells , Cloning, Molecular , Cyclic GMP/metabolism , DNA, Complementary/chemistry , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Gene Expression , Guanylate Cyclase/pharmacology , Molecular Sequence Data , Phylogeny , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Tissue Distribution
11.
Mol Endocrinol ; 15(10): 1693-705, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11579202

ABSTRACT

Gonadotropins are essential for ovarian follicular development and differentiation. To identify genes that are rapidly induced by gonadotropin in the immature rat ovary, ovarian genes were screened by a subtraction cloning procedure. cDNA clones encoding novel members of the (Cys)(2)-(His)(2)-type zinc finger protein family GIOT1 and -2 (gonadotropin-inducible transcription factor 1 and 2), were identified. Two isoforms of GIOT2 (GIOT2 alpha and 2 beta), which are probably produced by alternative splicing, also exist. Nucleotide sequence analysis revealed that GIOT1, but not GIOT2, contains the krüppel-associated box-A domain at the NH(2) terminus. RNA analyses revealed that these mRNAs were rapidly and temporarily induced by gonadotropins in the rat testis as well as in the ovary. In situ hybridization study revealed that expression of GIOT1 was induced in theca interna cells in the ovary and Leydig cells in the testis. Interestingly, the gene expression of GIOT1 is restricted to the pituitary, adrenal, testis, and ovary, while GIOT2 gene is expressed ubiquitously. A functional analysis of GIOT1 and -2 by a GAL4-based mammalian one-hybrid system revealed that GIOT1, but not GIOT2, is a transcriptional repressor and that the krüppel-associated box-A domain of GIOT1 is responsible for the transcriptional repressor activity. A GAL4-based yeast two-hybrid system was also used to identify proteins that interact with the rat GIOT1. We cloned genes encoding rat homologs of human I-mfa domain containing protein and transcriptional intermediary factor 1 beta, both of which are transcription-regulatory proteins. Interaction of these proteins with GIOT1 was directly demonstrated by GST pull-down assay. Our data strongly suggest that GIOT1 may function as a novel transcriptional repressor by working with rat homologs of human I-mfa domain containing protein and transcriptional intermediary factor 1 beta proteins and may play a significant role at the transcription level in the folliculogenesis.


Subject(s)
Saccharomyces cerevisiae Proteins , Transcription Factors/genetics , Zinc Fingers , 3T3 Cells , Alternative Splicing , Amino Acid Sequence , Animals , Cells, Cultured , Chorionic Gonadotropin/pharmacology , Cloning, Molecular , DNA Restriction Enzymes , DNA-Binding Proteins , Female , Follicle Stimulating Hormone/pharmacology , Fungal Proteins/genetics , Fungal Proteins/isolation & purification , Gene Expression/drug effects , Gonadotropins, Equine/pharmacology , Granulosa Cells/metabolism , Guanine Nucleotide Exchange Factors , In Situ Hybridization , Kinetics , Male , Membrane Proteins , Mice , Molecular Sequence Data , Myogenic Regulatory Factors/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/isolation & purification , Nucleic Acid Hybridization , RNA, Messenger/analysis , Rats , Rats, Wistar , Recombinant Fusion Proteins , Reverse Transcriptase Polymerase Chain Reaction , Saccharomyces cerevisiae/genetics , Tissue Distribution , Transcription Factors/chemistry , Transcription Factors/isolation & purification , Transcription Factors/physiology , Transfection
12.
Arch Biochem Biophys ; 390(1): 93-100, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11368520

ABSTRACT

A protein possessing vascular smooth muscle cell (SMC) growth-promoting activity (VSGP) was purified from bovine ovarian follicular fluid. The purified protein showed a broad band on SDS-PAGE with an apparent molecular mass of 90-100 kDa. The purified protein was characterized by amino acid sequence analysis of its N-terminal and internal peptides. Based on the information of the peptide sequences, bovine ovarian cDNA library was screened and cDNA clones encoding the protein were isolated. Human homolog of the protein was also cloned from human ovarian cDNA library. Nucleotide sequence analysis revealed that bovine VSGP transcript has a 2421-bp open reading frame, which encodes a protein of 807 amino acid residues. A homology search indicated that bovine and human VSGP are counterparts of rat F-spondin, which has been previously identified as a promoter molecule of neurite extension in rat fetal floor plate. RNA blot analysis showed wide distribution of VSGP/F-spondin transcripts in fetal and adult human tissues. Especially the expression was highest in the adult human ovary. The purified bovine VSGP/F-spondin showed vascular SMC growth promoting activity with an ED(50) value of 10(-8) M. Together with these findings, we demonstrated here that VSGP/F-spondin is a major factor for vascular SMC proliferation in the ovary. In conclusion, our present study provides a distinct and important function of VSGP/F-spondin as a strong VSMC proliferation promoting factor, in addition to the previously proposed function in neuronal system, and also provides insight into mechanisms underlying vascular SMC proliferation during ovarian folliculogenesis.


Subject(s)
DNA, Complementary/genetics , Follicular Fluid/chemistry , Growth Substances/genetics , Growth Substances/isolation & purification , Muscle, Smooth, Vascular/cytology , Peptides , Amino Acid Sequence , Animals , Base Sequence , Cattle , Cell Division/drug effects , Cloning, Molecular , DNA Primers/genetics , Extracellular Matrix Proteins , Female , Growth Substances/pharmacology , Humans , Molecular Sequence Data , Ovary/chemistry , RNA, Messenger/genetics , Sequence Homology, Amino Acid
13.
Life Sci ; 67(9): 1015-24, 2000.
Article in English | MEDLINE | ID: mdl-10954035

ABSTRACT

Steroidogenic acute regulatory protein (StAR) is a vital mitochondrial protein that is indispensable for the synthesis of steroids. To study the mechanisms of regulation of StAR in rat granulosa cells, we used granulosa cells obtained from diethylstilbestrol-treated immature rats. Northern blot analysis revealed two major transcripts of about 3.6 kb and 1.6 kb of rat StAR mRNA. Rat StAR mRNA had strongly increased within 2 h due to the treatment of FSH or 8-Br-cAMP in this culture, a parallel increase of transcripts of both sizes was observed. Compared to the control, StAR mRNA levels increased in a dose-dependent manner in the presence of increasing concentrations of FSH (1-100 ng/ ml) and 8-Br-cAMP (0.25-5 mM). Although co-treatment of rat granulosa cells with FSH and TGF-beta did not change FSH-induced StAR mRNA levels, these levels in granulosa cells were markedly increased by pretreatment with TGF-beta before being acutely (2 h) stimulated with an effective dose of FSH. The stimulatory effect of TGF-beta was time- and concentration-dependent (1-30 ng/ml).


Subject(s)
Granulosa Cells/metabolism , Phosphoproteins/biosynthesis , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Blotting, Northern , Cells, Cultured , Dose-Response Relationship, Drug , Female , Follicle Stimulating Hormone/pharmacology , Granulosa Cells/drug effects , Kinetics , Phosphoproteins/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptors, FSH/biosynthesis , Receptors, FSH/genetics , Transforming Growth Factor beta/pharmacology
14.
Clin Cancer Res ; 6(7): 2764-70, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10914722

ABSTRACT

Activin receptors (ActRs) and gonadotropin receptor mRNA expression were investigated in 18 human ovarian epithelial neoplasms. Northern blot analysis showed the presence of 3.0-kb type Ia ActR, 6.0- and 3.0-kb type IIa ActR, and 5.0-kb type IIb ActR mRNA transcripts in total RNA prepared from the cancer tissues. One carcinoma showed two major transcripts of a follicle-stimulating hormone receptor (FSH-R) gene, 4.1 and 2.4 kb, whereas the other two carcinomas showed two major transcripts of the luteinizing hormone/human chorionic gonadotropin receptor (LH-R) gene, 5.4 and 2.4 kb. These results were further analyzed by studying the corresponding PCR-amplified FSH and LH-R cDNA obtained by reverse transcription of total RNA. Expression of FSH-R mRNA was confirmed in about half of the cancer tissues. The size of the FSH-R reverse transcription-PCR product was the same as in normal ovarian follicles. Similarly, expression of LH-R mRNA was also detected in about half of the cancers. Normal ovaries and cancer tissues were homogenized, and activin concentrations were measured in extracts. Activin levels in normal ovarian tissue were around 0.59 +/- 0.01 ng/mg protein (mean +/- SE; n = 5), and activin production was detected in every cancer tissue, except one--serous adenocarcinoma. The findings in this study demonstrated that activin and ActRs are present in and synthesized by human ovarian epithelial neoplasms. Thus, activin seems to be available as an autocrine/paracrine factor in epithelial neoplasms and may contribute to the expression of FSH-R, although the roles of activin and gonadotropin in tumorigenesis has yet to be defined.


Subject(s)
Carcinoma/genetics , Ovarian Neoplasms/genetics , Receptors, Gonadotropin/genetics , Receptors, Growth Factor/genetics , Transcription, Genetic , Activin Receptors , Activins , Adult , Aged , Blotting, Northern , Carcinoma/chemistry , Carcinoma/classification , Carcinoma/pathology , Female , Humans , Inhibins/analysis , Middle Aged , Ovarian Neoplasms/chemistry , Ovarian Neoplasms/pathology , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction
15.
Fertil Steril ; 74(1): 141-5, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10899511

ABSTRACT

OBJECTIVE: Adrenomedullin (AM) is a potent hypotensive peptide found in human pheochromocytoma tissue. In the present study, the expression of AM mRNA in the human ovary was examined. DESIGN: Ovarian mRNA was analyzed in the follicle, the corpus luteum of mid-luteal phase, and early pregnancy. SETTING: Gunma University School of Medicine, Gunma, Japan. PATIENT(S): Premenopausal women with histologically normal ovary who were undergoing salpingoophorectomy. INTERVENTION(S): The dominant follicle and corpora lutea were isolated and total RNA was extracted from these tissues. MAIN OUTCOME MEASURE(S): Northern blot analysis of AM, receptor activity-modifying protein 2 (RAMP2), and LH/hCG receptor mRNA in human samples. RESULT(S): An AM mRNA transcript of 1.6 kilobases (kb) was detected in corpus luteum tissue; this transcript was identical to that which has been detected in placenta and fetal membrane. The AM and LH/hCG receptor mRNA levels were low in the mature follicle but increased in the corpus luteum of the mid-luteal phase and were maintained during early pregnancy. A single transcript of 0.8 kb for RAMP2 was also seen in the follicle and corpus luteum, the level of RAMP2 mRNA was relatively high in the preovulatory follicle and RAMP2 was present in the corpus luteum. CONCLUSION(S): The expression of AM, its receptor, and LH/hCG receptor may be an important component in the process of development and differentiation of the corpus luteum.


Subject(s)
Corpus Luteum/metabolism , Peptides/metabolism , Adrenomedullin , Blotting, Northern , Electrophoresis, Polyacrylamide Gel , Female , Glycosylation , Humans , Intracellular Signaling Peptides and Proteins , Membrane Proteins/biosynthesis , Molecular Weight , Pregnancy , Premenopause , RNA, Messenger/metabolism , Receptor Activity-Modifying Protein 2 , Receptor Activity-Modifying Proteins , Receptors, LH/biosynthesis , Receptors, LH/genetics
16.
J Biol Chem ; 275(29): 22512-9, 2000 Jul 21.
Article in English | MEDLINE | ID: mdl-10801817

ABSTRACT

The scavenger receptor class B type I (SR-BI) mediates the selective transport of lipids from high density lipoprotein to cells and plays an important role in the reverse uptake of cholesterol to the liver and in the delivery of substrates for steroidogenesis in steroidogenic organs. We report here on the isolation and characterization of the upstream promoter region of the rat SR-BI gene. The transcription start site for rat SR-BI was mapped, and DNA sequence analysis revealed the presence of binding sites for the Sp1 family in the proximal 5'-flanking region. Analysis of deletion mutants with different 5' lengths revealed that the region between -121 and -90 base pairs from the transcription start site is essential for the efficient transcription of SR-BI. Both Sp1 and Sp3 bind to three GC boxes in the region (-141 to -1 base pairs) in a sequence-specific manner. Mutations in any of the GC boxes decreased efficient transcription from this promoter in MA-10 mouse Leydig tumor cells. The overexpression of Sp1 or Sp3 protein enhanced the rat SR-BI promoter activity. These results indicate that Sp1 family members of transcription factors are essential for transcription of the rat SR-BI gene.


Subject(s)
Membrane Proteins , Receptors, Immunologic/genetics , Receptors, Lipoprotein , Transcriptional Activation , Animals , Base Sequence , CD36 Antigens , HeLa Cells , Humans , Mice , Molecular Sequence Data , Promoter Regions, Genetic , Rats , Receptors, Scavenger , Scavenger Receptors, Class B
17.
Biol Reprod ; 62(5): 1224-30, 2000 May.
Article in English | MEDLINE | ID: mdl-10775170

ABSTRACT

Activin A has been shown to exert several regulatory functions on human placenta. In the present study, we tested the hypothesis that activin A is an autocrine regulator of trophoblast using a choriocarcinoma cell line, JEG-3, as a model. Messenger RNAs for activin beta(A) subunit, activin binding protein (follistatin), and various activin receptors, including ActR-IA, ActR-IB, ActR-IIA, and ActR-IIB, were detected in JEG-3 cells by reverse transcription-polymerase chain reaction. The expression of activin A in JEG-3 cells was further confirmed by Western blot analysis using an antibody against activin beta(A) subunit. Using Northern blot analysis, Smad-2 and Smad-4 mRNAs were also observed in JEG-3 cells. These data suggest that JEG-3 cells produce activin A and express activin binding proteins and receptors, as well as potential downstream signals. In cultured JEG-3 cells, basal progesterone production was stimulated by activin A but inhibited by follistatin-288. Similarly, in the presence of androstenedione, estradiol production was enhanced by activin A but decreased by follistatin-288. On the other hand, neither activin A nor follistatin affected JEG-3 cell growth. Taken together, these findings strongly suggest that activin A is an autocrine factor that is involved in the regulation of progesterone and estradiol production in JEG-3 cells.


Subject(s)
Inhibins/metabolism , Steroids/metabolism , Trophoblasts/metabolism , Activin Receptors , Activins , Autocrine Communication , Cell Division/drug effects , Choriocarcinoma , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Estradiol/biosynthesis , Follistatin , Glycoproteins/metabolism , Glycoproteins/pharmacology , Humans , Inhibins/pharmacology , Progesterone/biosynthesis , Receptors, Growth Factor/genetics , Receptors, Growth Factor/metabolism , Smad2 Protein , Smad4 Protein , Time Factors , Trans-Activators/genetics , Trans-Activators/metabolism , Tumor Cells, Cultured
18.
Endocrinology ; 141(4): 1470-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10746652

ABSTRACT

Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin; TCDD) is a common environmental pollutant causing public concern. Using a cell culture system derived from rat granulosa cells that provides unique advantages for studying the molecular mechanisms underlying the action of TCDD, the influences of TCDD on FSH receptor (FSH-R) induction were examined. The treatment with FSH produced, as expected, a substantial increase in specific FSH-R expression, whereas concurrent treatment with the environmental amount of TCDD (10 pM) resulted in a significant decrease in FSH-R after being cultured from 24-72 h. Cotreatment with FSH (30 ng/ml) and increasing doses of TCDD inhibited the levels of FSH-induced FSH-R messenger RNA (mRNA) in a dose-dependent manner. Treatment with 8-Br-cAMP (1 mM) produced a significant increase in FSH-R mRNA; concurrent treatment with TCDD (10 pM) produced a significant attenuation of 8-Br-cAMP action. These findings suggest that the ability of TCDD to interfere with FSH action, as regards the induction of FSH-Rs, is exerted at sites distal to those involved in cAMP generation. Because a single transcript of 5.2 kb was seen for the Ah receptor in this granulosa cell system, the effects of TCDD may be mediated by this specific receptor. The rates of FSH-R mRNA gene transcription, assessed by nuclear run-on transcription assay, were decreased by the addition of TCDD. The effect of TCDD on FSH-R mRNA stability was determined by measuring the decay of FSH-R mRNA under conditions known to inhibit transcription. The decay curve for the 2.4-kb FSH-R mRNA transcript was not significantly changed after the addition of TCDD. These findings showed that the effect of TCDD on FSH-R mRNA was, at least in part, the result of decreased transcription.


Subject(s)
Environmental Pollutants/pharmacology , Granulosa Cells/drug effects , Granulosa Cells/metabolism , Polychlorinated Dibenzodioxins/pharmacology , Receptors, FSH/metabolism , 8-Bromo Cyclic Adenosine Monophosphate/antagonists & inhibitors , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Cell Differentiation/physiology , Cells, Cultured , Female , Follicle Stimulating Hormone/pharmacology , RNA Stability/drug effects , RNA, Messenger/antagonists & inhibitors , Rats , Rats, Wistar , Receptors, FSH/antagonists & inhibitors , Receptors, FSH/genetics , Transcription, Genetic/drug effects
19.
Br J Cancer ; 82(8): 1415-20, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10780520

ABSTRACT

In this study, we have investigated the expression of inhibin subunits and activin receptors (ActRs) in normal and malignant ovarian cells. Each product of the inhibin subunits (alpha, betaa, betab) and activin receptors (ActRs) amplified by reverse transcription polymerase chain reaction were detected as a single band in human granulosa cells, surface epithelial cells (OSE), and the ovarian cancer cell lines OVCAR 3 and SKOV 3. Western blot analysis was performed using polyclonal antibodies against ActR IIa or IIb peptides based on 13 COOH-terminal amino acids; cultured human granulosa cells were used as a positive control. Using ActR IIa antibody, one major band corresponding to approximately 80 kDa and one minor band corresponding to 105 kDa were observed in the samples. One single band at approximately 60 kDa was detected in OVCAR 3 and a 50 kDa band was detected with ActR IIb antibody in cultured granulosa cell, OSE and SKOV 3. Although no detectable change was induced in Smad 4 mRNA in OVCAR 3, Smad 2 mRNA levels were increased during 48 h treatment with activin A (50 ng ml(-1)). These data provide a better understanding as the first step in the mechanism of action of the activin in the epithelial ovarian carcinoma.


Subject(s)
Adenocarcinoma/physiopathology , Epithelial Cells/physiology , Inhibins/physiology , Ovarian Neoplasms/physiopathology , Ovary/physiology , Signal Transduction , Activin Receptors , Activins , Adenocarcinoma/pathology , DNA-Binding Proteins/genetics , Epithelial Cells/cytology , Epithelial Cells/pathology , Female , Granulosa Cells/cytology , Granulosa Cells/physiology , Growth Substances/physiology , Humans , Inhibins/genetics , Ovarian Neoplasms/pathology , Ovary/cytology , Ovary/pathology , Receptors, Growth Factor/genetics , Reverse Transcriptase Polymerase Chain Reaction , Smad2 Protein , Smad4 Protein , Trans-Activators/genetics , Transcription, Genetic , Tumor Cells, Cultured
20.
Arch Biochem Biophys ; 375(2): 371-6, 2000 Mar 15.
Article in English | MEDLINE | ID: mdl-10700395

ABSTRACT

Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) is a common environmental pollutant causing public concern. By use of a cell culture system derived from rat granulosa cells that provides unique advantages for studying the molecular mechanisms underlying the action of TCDD, the influence of TCDD on luteinizing hormone receptor (LHR) induction was examined. Treatment with follicle-stimulating hormone (FSH) produced, as expected, a substantial increase in specific LHR expression; concurrent treatment with TCDD (10 pM) resulted in a significant decrease in LHR after 24 h. Cotreatment with 30 ng/ml FSH and increasing doses of TCDD inhibited the levels of FSH-induced LHR mRNA in a dose-dependent manner, and 1 pM TCDD inhibited FSH-induced LHR significantly after 48 h. The rate of LHR mRNA gene transcription, assessed by nuclear run-on transcription assay, was found to decrease after addition of TCDD. The decay curves for the 5.4-kb LHR mRNA transcript showed a significant decrease after addition of TCDD.


Subject(s)
Environmental Pollutants/pharmacology , Gene Expression Regulation/drug effects , Granulosa Cells/cytology , Granulosa Cells/drug effects , Polychlorinated Dibenzodioxins/pharmacology , Receptors, LH/genetics , Animals , Cell Differentiation/drug effects , Cells, Cultured , Dactinomycin/pharmacology , Dose-Response Relationship, Drug , Environmental Pollutants/toxicity , Female , Follicle Stimulating Hormone/antagonists & inhibitors , Follicle Stimulating Hormone/pharmacology , Granulosa Cells/metabolism , Half-Life , Polychlorinated Dibenzodioxins/toxicity , RNA Stability/drug effects , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar , Time Factors , Transcription, Genetic/drug effects , Transcription, Genetic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL